Trina Solar Limited (NYSE:TSL) shares remains unchanged in last trading session and ended the day at $9.91. TSL Gross Margin is 17.60% and its has a return on assets of 2.40%. Trina Solar Limited (NYSE:TSL) quarterly performance is 8.78%.
Trina Solar Limited (NYSE:TSL) is pleased to announce that it has signed a supply agreement with Toyo Engineering Corporation (“Toyo Engineering”) to ship a total of 96.2 MW of solar modules to the Hosoe Mega Solar Project (the “Project”), which is developed by Pacifico Energy K.K. and expected to be the largest solar project in Kyushu, Japan.
Alcobra Ltd. (NASDAQ:ADHD) ended the last trading day at $5.82. Company weekly volatility is calculated as 4.42% and price to cash ratio as 4.49. Alcobra Ltd. (NASDAQ:ADHD) showed a weekly performance of -7.18%.
Alcobra Ltd. (NASDAQ:ADHD), announced participation in a panel titled “Underdiscovered NeuroInnovators” at the Piper Jaffray 27th Annual Healthcare Conference on 2 December, 2015.
On 10 December, Fluor Corporation (NYSE:FLR) shares increased 0.38% and was closed at $45.49. FLR EPS growth in last 5 year was 3.60%. Fluor Corporation (NYSE:FLR) year to date (YTD) performance is -23.74%.
On 7 December, Fluor Corporation (NYSE:FLR) and Stork announced that Fluor has signed an agreement with UK-based private equity firm Arle Capital Partners to acquire 100 percent of Stork Holding B.V., based in the Netherlands, for an investment of €695 million ($755 million).
Huaneng Power International, Inc. (NYSE:HNP) shares moved down -1.75% in last trading session and ended the day at $34.22. HNP Gross Margin is 96.70% and its has a return on assets of 8.80%. Huaneng Power International, Inc. (NYSE:HNP) quarterly performance is -24.84%.
Huaneng Power International Inc (NYSE:HNP) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Friday, Analyst Ratings Network.com reports.
Second Sight Medical Products, Inc. (NASDAQ:EYES) caters to the Healthcare space. Its weekly performance is 16.73%. On the last day of trading company shares ended up at $6.00. Second Sight Medical Products, Inc. (NASDAQ:EYES) distance from 50-day simple moving average (SMA50) is 0.03%.
On December 1, 2015, Second Sight Medical Products, Inc. (NASDAQ:EYES) Board of Directors approved the grant of 190,000 inducement restricted stock units (“RSUs”) to Will McGuire, the Company’s chief executive officer. The award will vest over four years, with 25 percent (25%) of the underlying shares vesting on August 18, 2016, which is the first anniversary of Mr. McGuire’s employment with the Company, and thereafter in twelve equal installments of six and one quarter percent (6.25%) on the next twelve quarterly periods. Each RSU unit upon vesting entitles Mr. McGuire toreceive one share of the common stock of the Company.
Leave a Reply